Şahin, A. B., Cubukcu, E., Ocak, B., Deligonul, A., Orhan, S. O., Tolunay, S., . . . Evrensel, T. (2021). Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy. Nature Portfolio.
Chicago Style (17th ed.) CitationŞahin, Ahmet Bilgehan, et al. Low Pan-immune-inflammation-value Predicts Better Chemotherapy Response and Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Nature Portfolio, 2021.
MLA (8th ed.) CitationŞahin, Ahmet Bilgehan, et al. Low Pan-immune-inflammation-value Predicts Better Chemotherapy Response and Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.